ASP-8731
- Generic Name
- ASP-8731
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- -
- CAS Number
- 2488255-42-9
- Unique Ingredient Identifier
- UY57S27WMN
- Background
ASP-8731 is a novel BACH1 inhibitor that potentially induces fetal hemoglobin (HbF). Developed by Mitobridge, it is being investigated for the treatment of sickle cell disease.
- Associated Conditions
- -
- Associated Therapies
- -
A Study to Find a Suitable Dose of ASP8731 and Check for Medical Problems at Each Dose in Healthy Adults
Phase 1
Terminated
- Conditions
- Interventions
- First Posted Date
- 2021-12-22
- Last Posted Date
- 2024-11-20
- Lead Sponsor
- Astellas Pharma Global Development, Inc.
- Target Recruit Count
- 36
- Registration Number
- NCT05167526
- Locations
- 🇺🇸
California Clinical Trials Medical Group, Glendale, California, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath